about
Hematopoietic cytokines as tumor markersA Practical Guide to Immunoassay Method ValidationHypogelsolinemia, a disorder of the extracellular actin scavenger system, in patients with multiple sclerosisThe diagnostic value of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of matrix metalloproteinases 1 (TIMP-1) determination in the sera of colorectal adenoma and cancer patients.Increased levels of sphingosine-1-phosphate in cerebrospinal fluid of patients diagnosed with tick-borne encephalitisComparison between clinical significance of serum proinflammatory proteins (IL-6 and CRP) and classic tumor markers (CEA and CA 19-9) in gastric cancer.Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.The Serum Concentrations of Chemokine CXCL12 and Its Specific Receptor CXCR4 in Patients with Esophageal Cancer.Serum levels and tissue expression of matrix metalloproteinase 2 (MMP-2) and tissue inhibitor of metalloproteinases 2 (TIMP-2) in colorectal cancer patients.Cerebrospinal fluid leakage--reliable diagnostic methods.Gastric cancer - The role of matrix metalloproteinases in tumor progression.Interleukin 6 and C-reactive protein in esophageal cancer.The role of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the pathophysiology of neurodegeneration: a literature study.Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in the tumors of central nervous system (CNS).Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in amyotrophic lateral sclerosis (ALS).Cerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases.Biomarkers of Alzheimer's disease and mild cognitive impairment: a current perspective.Chemokines and their receptors in esophageal cancer--the systematic review and future perspectives.The Role of Visinin-Like Protein-1 in the Pathophysiology of Alzheimer's Disease.The Relationship between Markers of Inflammation and Degeneration in the Central Nervous System and the Blood-Brain Barrier Impairment in Alzheimer's Disease.Biochemical and Radiological Markers of Alzheimer's Disease Progression.Systematic biobanking, novel imaging techniques, and advanced molecular analysis for precise tumor diagnosis and therapy: The Polish MOBIT project.YKL-40 as a Potential Biomarker and a Possible Target in Therapeutic Strategies of Alzheimer's Disease.Matrix Metalloproteinases and Their Tissue Inhibitors in Comparison to Other Inflammatory Proteins in Gastric Cancer (GC).Hypotensive effect of atorvastatin in hypertensive patients: the association among flow-mediated dilation, oxidative stress and endothelial dysfunction.Application of multiplexing technology to the analysis of the intrathecally released immunoglobulins against B. burgdorferi antigens in neuroborreliosis.The role of endothelium-derived mediators in exercise-induced bronchoconstriction.Depletion of plasma gelsolin in patients with tick-borne encephalitis and Lyme neuroborreliosis.Endothelial dysfunction and sympathetic nervous system activation in young patients with essential arterial hypertension and without hypercholesterolaemia.Hypotensive effect of atorvastatin is not related to changes in inflammation and oxidative stress.Changes in high-sensitivity C-reactive protein in serum and exhaled breath condensate after intensive exercise in patients with allergic asthma.Influence of atorvastatin on blood pressure control in treated hypertensive, normolipemic patients - An open, pilot study.The diagnostic value of alcohol dehydrogenase (ADH) isoenzymes and aldehyde dehydrogenase (ALDH) measurement in the sera of colorectal cancer patients.RANTES in exhaled breath condensate of allergic asthma patients with exercise-induced bronchoconstriction.Plasma concentrations of the amyloid-β peptides in young volunteers: the influence of the APOE genotype.Profiling of selected angiogenesis-related genes in proliferative eutopic endometrium of women with endometriosis.Matrix metalloproteinase 2 (MMP-2) and their tissue inhibitor 2 (TIMP-2) in gastric cancer patients.The importance of interleukin 18, glutathione peroxidase, and selenium concentration changes in acute pancreatitis.Serum tissue inhibitor of metalloproteinase 1 (TIMP-1) and vascular endothelial growth factor A (VEGF-A) are associated with prognosis in esophageal cancer patients.Diagnostic biomarkers of essential arterial hypertension: the value of prostacyclin, nitric oxide, oxidized-LDL, and peroxide measurements.
P50
Q28296229-68B31561-2923-43EA-9442-74CA7D6D2D00Q30661695-23DFD949-7FB5-42A5-97E8-DB902EA8AC7AQ33735371-4D5FD316-C514-4E72-92FC-493181A0B2ACQ34084897-B100263F-9EED-4F48-878A-DFC099DB5789Q34645463-DDCD00EC-880E-4630-BF30-DA33BE6D35B8Q34919435-2E43D492-70C3-44C6-B35A-41507768518BQ35800785-5A9DD17A-9B22-4E95-861F-4799F2964774Q36693716-C161C699-4660-4F6F-B874-BF3D8E599132Q37692836-981D5187-C937-49E4-B152-96C25224B738Q37844886-B1391A7D-0B1B-4397-8090-53CD01ADFCD4Q37892680-443A2CA0-5657-4857-A681-D61407826F94Q38011546-0849D866-C6FD-413B-97EF-CE01676A93D0Q38116350-B70D06F5-DDEF-464B-B9A7-9424DA004FD8Q38173695-940A8711-E21A-4253-8009-9A4D63EE63C6Q38232360-11FCA19A-A1EA-4FC9-92B7-A70B0C9EA33DQ38289739-8B5EC96D-67D7-4F19-B73C-2524CCE1CB30Q38314750-95480739-7205-40EB-B093-AF30564668A9Q38541163-13DBD5AF-0F95-4EEA-83E5-31A89DB2AB0CQ38592265-566AB874-B0B9-4409-9141-7CDC592BD230Q38683919-515BF680-C607-471E-BAD3-3C83093B7BC3Q38693438-FF62D455-4EAD-4110-9FA1-5497F9D5B67AQ38710900-A6C5BEF9-4066-408A-A340-FCF3210F0BCFQ38759253-9A5D489C-1A00-4457-8CB5-1507EC8557E8Q38896287-86DD4C12-F685-4791-87B6-673C3899F7FDQ40623951-AEEFBF5A-2CA1-4F94-B171-6657E1BEB0EBQ41090189-ED3B1BDD-5D83-44CF-8BED-F3CA984B701BQ42170853-04FDD3D6-593E-4E3A-9227-249EDED56B3CQ42770834-A099D939-261C-4E89-954E-9094D4B70A91Q42787498-A9031675-582A-49BD-B337-DD9C55B88A00Q42794524-9782212B-6B65-4A0B-AA93-D080B63C8684Q43112815-1FC40038-11AA-4DDF-8717-23AF74DA5BADQ43195720-DB772B63-9DD2-4AA8-B0D9-DE563C545E93Q43195950-3FE1592A-BB1C-4F3C-B1D3-4DEF072D4FFFQ43227195-546AFE4D-C539-461F-918B-19F97FBFB14CQ44109570-234EE791-509B-4977-B0E8-819507FD4F12Q44506501-5A9D89E7-D97F-4E8D-A0E0-408192DF03D2Q44549101-982E906C-F5AE-4728-B5C2-8F774ECFE149Q44928108-C222D42E-F12A-4B6B-8738-61C8FDFCF5BAQ45263766-86C077BF-540D-40B9-A954-E70BAD4F00C0Q45977675-CB32ADC1-A61C-4260-BFDC-D1FD16D5B46B
P50
description
onderzoeker
@nl
researcher, ORCID id # 0000-0002-4075-8479
@en
name
Barbara Mroczko
@ast
Barbara Mroczko
@en
Barbara Mroczko
@es
Barbara Mroczko
@nl
type
label
Barbara Mroczko
@ast
Barbara Mroczko
@en
Barbara Mroczko
@es
Barbara Mroczko
@nl
altLabel
BARBARA MROCZKO
@en
prefLabel
Barbara Mroczko
@ast
Barbara Mroczko
@en
Barbara Mroczko
@es
Barbara Mroczko
@nl
P1053
R-5955-2018
P106
P1153
7003702342
P21
P214
47152682565823311090
P31
P496
0000-0002-4075-8479
P734
P735
P7859
viaf-47152682565823311090